Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yossef Lerner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|May 4, 2026
Slower Progression Rates in Lower Limb-Onset ALSYehuda Shovman, Yossef Lerner, Marc Gotkine
Rambam Maimonides Medical Journal|September 16, 2022
A Unique Case of MyositisNoa Hurvitz, Ariel Kenig, Asa Kessler, et al.
Muscle & Nerve|March 19, 2025
Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label StudyMarc Gotkine, David A Schoenfeld, Ilana Cohen, et al.
Journal of Translational Medicine|February 15, 2023
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial resultsMarc Gotkine, Yoseph Caraco, Yossef Lerner, et al.
Neurobiology of Aging|July 17, 2021
A recessive S174X mutation in Optineurin causes amyotrophic lateral sclerosis through a loss of function via allele-specific nonsense-mediated decayMarc Gotkine, Martina de Majo, Chun Hao Wong, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Science Translational Medicine|February 23, 2022
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALSPaul J Hop, Ramona A J Zwamborn, Eilis Hannon, et al.
Nature Genetics|March 31, 2026
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosisPaul J Hop, Maarten Kooyman, Brendan J Kenna, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|May 4, 2026
Slower Progression Rates in Lower Limb-Onset ALSYehuda Shovman, Yossef Lerner, Marc Gotkine
Rambam Maimonides Medical Journal|September 16, 2022
A Unique Case of MyositisNoa Hurvitz, Ariel Kenig, Asa Kessler, et al.
Muscle & Nerve|March 19, 2025
Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label StudyMarc Gotkine, David A Schoenfeld, Ilana Cohen, et al.
Journal of Translational Medicine|February 15, 2023
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial resultsMarc Gotkine, Yoseph Caraco, Yossef Lerner, et al.
Neurobiology of Aging|July 17, 2021
A recessive S174X mutation in Optineurin causes amyotrophic lateral sclerosis through a loss of function via allele-specific nonsense-mediated decayMarc Gotkine, Martina de Majo, Chun Hao Wong, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Science Translational Medicine|February 23, 2022
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALSPaul J Hop, Ramona A J Zwamborn, Eilis Hannon, et al.
Nature Genetics|March 31, 2026
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosisPaul J Hop, Maarten Kooyman, Brendan J Kenna, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 2